Αποτελέσματα αναζήτησης - Jenny F. Seligmann
- Εμφανίζονται 1 - 8 Αποτελέσματα από 8
-
1
The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer από Julien Taı̈eb, Andreas Jung, Andrea Sartore‐Bianchi, Marc Peeters, Jenny F. Seligmann, Aziz Zaanan, Peter Burdon, Clara Montagut, Pierre Laurent‐Puig
Έκδοση 2019Revisão -
2
Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With<i>RAS</i>Wild-Type Advanced Col... από Jenny F. Seligmann, Faye Elliott, Susan D. Richman, Bart Jacobs, Gemma Hemmings, Sarah Brown, Jennifer H. Barrett, Sabine Tejpar, Philip Quirke, Michel Seymour
Έκδοση 2016Artigo -
3
Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up από Andrés Cervantes, R. Adam, Susana Roselló, Dirk Arnold, Nicola Normanno, Julien Taı̈eb, Jenny F. Seligmann, Thierry de Baère, Pia Österlund, Takayuki Yoshino, Erika Martinelli
Έκδοση 2022Artigo -
4
Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial από Dion Morton, Michel Seymour, Laura Magill, Kelly Handley, James Glasbey, Bengt Glimelius, Andy Palmer, Jenny F. Seligmann, Søren Laurberg, Keigo Murakami, Nicholas P. West, Philip Quirke, Richard Gray
Έκδοση 2023Artigo -
5
Investigating the poor outcomes ofBRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials από Jenny F. Seligmann, David J. Fisher, Christopher G. Smith, Susan D. Richman, Faye Elliott, Sarah Brown, Richard Adams, Tim Maughan, Philip Quirke, Jeremy P. Cheadle, Michel Seymour, Gary Middleton
Έκδοση 2016Artigo -
6
Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS , and NRAS (FOCUS4-D): a phase 2–3 randomised trial από Richard Adams, Ewan Brown, Louise Brown, Rachel Butler, Stephen Falk, David J. Fisher, Richard Kaplan, Philip Quirke, Susan D. Richman, Leslie Samuel, Jenny F. Seligmann, Michel Seymour, Kai Keen Shiu, Harpreet Wasan, Richard H. Wilson, Tim Maughan
Έκδοση 2017Artigo -
7
Inhibition of WEE1 Is Effective in<i>TP53</i>- and<i>RAS</i>-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitori... από Jenny F. Seligmann, David J. Fisher, Louise Brown, Richard Adams, Janet Graham, Philip Quirke, Susan D. Richman, Rachel Butler, Enric Domingo, Andrew Blake, Emma Yates, Michael Braun, Fiona Collinson, Robert H. Jones, Ewan Brown, Emma De Winton, Timothy C. Humphrey, Mahesh Parmar, Richard Kaplan, Richard H. Wilson, Michel Seymour, Tim Maughan
Έκδοση 2021Artigo -
8
Evaluation of CD3 and CD8 T-Cell Immunohistochemistry for Prognostication and Prediction of Benefit From Adjuvant Chemotherapy in Early-Stage Colorectal Cancer Within the QUASAR Tr... από Christopher J.M. Williams, Richard Gray, Robert K. Hills, Michael Shires, Liping Zhang, Zuo Zhao, Tracie Gardner, Nancy Sapanara, Xiaomeng Xu, Isaac Bai, Dongyao Yan, Andrea Murányi, Sarah Dance, Faranak Aghaei, Gemma Hemmings, Michael Hale, Uday Kurkure, Christoph Guetter, Susan D. Richman, Gordon Hutchins, Jenny F. Seligmann, Nicholas P. West, Shalini Singh, Kandavel Shanmugam, Philip Quirke
Έκδοση 2024Artigo
Εργαλεία αναζήτησης:
Σχετικά θέματα
Cancer
Colorectal cancer
Internal medicine
Medicine
Oncology
Biology
Chemotherapy
Clinical trial
Gastroenterology
Panitumumab
Biochemistry
Biomarker
Gene
Irinotecan
KRAS
Oxaliplatin
Paleontology
Progression-free survival
Randomized controlled trial
Stage (stratigraphy)
Adjuvant therapy
Allele
Amphiregulin
Bioinformatics
Biomarker discovery
CD8
Cancer research
Cell cycle
Cetuximab
Clinical Practice